The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $80.98

Today's change-0.19 -0.23%
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $80.98

Today's change-0.19 -0.23%
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.

Gilead Sciences Inc down (U.S.)$0.19

Gilead Sciences Inc closed lower Friday, dropping (U.S.)$0.19 or 0.23% to (U.S.)$80.98. Over the last five days, shares have gained 2.48% and 13.15% over the last 52 weeks. However, this lagged the 24.15%. gain in the S&P 500.

Key company metrics

  • Open(U.S.) $81.30
  • Previous close(U.S.) $81.17
  • High(U.S.) $81.53
  • Low(U.S.) $80.37
  • Bid / Ask(U.S.) $80.98 / (U.S.) $81.11
  • YTD % change+13.04%
  • Volume7,920,878
  • Average volume (10-day)8,767,589
  • Average volume (1-month)8,085,104
  • Average volume (3-month)8,219,511
  • 52-week range(U.S.) $63.76 to (U.S.) $86.27
  • Beta1.20
  • Trailing P/E9.22×
  • P/E 1 year forward9.30×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.57%
  • Trailing EPS(U.S.) $8.79
Updated January 19 4:15 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue6,5127,1416,5057,320
Total other revenue--------
Total revenue6,5127,1416,5057,320
Gross profit5,4806,0155,5486,245
Total cost of revenue1,0321,1269571,075
Total operating expense2,7002,8872,7383,275
Selling / general / administrative879897850992
Research & development7898649311,208
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income3,8124,2543,7674,045
Interest income (expense), net non-operating-291-269-261-265
Gain (loss) on sale of assets--------
Other--------
Income before tax3,6714,1153,6173,920
Income after tax2,7123,0692,6993,099
Income tax, total9591,046918821
Net income2,7183,0732,7023,108
Total adjustments to net income--------
Net income before extra. items2,7183,0732,7023,108
Minority interest6439
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,7183,0732,7023,108
Inc. avail. to common incl. extra. items2,7183,0732,7023,108
Diluted net income2,7183,0732,7023,108
Dilution adjustment--000
Diluted weighted average shares1,3191,3171,3201,325
Diluted EPS excluding extraordinary itemsvalue per share2.062.332.052.35
Dividends per sharevalue per share0.520.520.520.47
Diluted normalized EPSvalue per share2.062.332.052.35